Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers

Lauren Scheuer, Noah Kauff, Mark Robson, Bridget Kelly, Richard Barakat, Jaya Satagopan, Nathan Ellis, Martee Hensley, Jeff Boyd, Patrick Borgen, Larry Norton, Kenneth Offit

Research output: Contribution to journalArticle

377 Citations (Scopus)

Abstract

Purpose: To prospectively determine the impact of genetic counseling and testing on risk-reduction strategies and cancer incidence in a cohort of individuals at hereditary risk for breast and ovarian cancer. Patients and Methods: Two hundred fifty-one individuals with BRCA mutations were identified at a single comprehensive cancer center from May 1, 1995, through October 31, 2000. Uniform recommendations regarding screening and preventive surgery were provided in the context of genetic counseling. Patients were followed for a mean of 24.8 months (range, 1.6 to 66.0 months) using standardized questionnaires, chart reviews, and contact with primary physicians. Results: Frequency of cancer surveillance by physical examinations and imaging studies increased after genetic counseling and testing. Twenty-one breast, ovarian, primary peritoneal, or fallopian tube cancers were detected after receipt of genetic test results. Among 29 individuals choosing risk-reducing mastectomy after testing, two were found to have occult intraductal breast cancers. Among 90 individuals who underwent risk-reducing salpingo-oophorectomy, one early-stage ovarian neoplasm and one early-stage fallopian tube neoplasm were found. Radiographic or tumor marker-based screening detected six breast cancers, five of which were stage 0/1, one early-stage primary peritoneal cancer, and three stage I or II ovarian cancers. Six additional breast cancers were detected by physical examination between radiographic screening intervals; four of these six tumors were stage I. No stage III or stage IV malignancies were detected after genetic testing. Conclusion: This study provides prospective evidence that genetic counseling and testing increased surveillance and led to risk-reducing operations, which resulted in diagnosis of early-stage tumors in patients with BRCA1 and BRCA2 mutations.

Original languageEnglish (US)
Pages (from-to)1260-1268
Number of pages9
JournalJournal of Clinical Oncology
Volume20
Issue number5
DOIs
StatePublished - Mar 1 2002
Externally publishedYes

Fingerprint

Ovarian Neoplasms
Breast Neoplasms
Genetic Counseling
Genetic Testing
Mutation
Fallopian Tube Neoplasms
Neoplasms
Physical Examination
Mastectomy
Ovariectomy
Risk Reduction Behavior
Tumor Biomarkers
Breast
Prospective Studies
Physicians
Incidence

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Scheuer, L., Kauff, N., Robson, M., Kelly, B., Barakat, R., Satagopan, J., ... Offit, K. (2002). Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. Journal of Clinical Oncology, 20(5), 1260-1268. https://doi.org/10.1200/JCO.20.5.1260

Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. / Scheuer, Lauren; Kauff, Noah; Robson, Mark; Kelly, Bridget; Barakat, Richard; Satagopan, Jaya; Ellis, Nathan; Hensley, Martee; Boyd, Jeff; Borgen, Patrick; Norton, Larry; Offit, Kenneth.

In: Journal of Clinical Oncology, Vol. 20, No. 5, 01.03.2002, p. 1260-1268.

Research output: Contribution to journalArticle

Scheuer, L, Kauff, N, Robson, M, Kelly, B, Barakat, R, Satagopan, J, Ellis, N, Hensley, M, Boyd, J, Borgen, P, Norton, L & Offit, K 2002, 'Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers', Journal of Clinical Oncology, vol. 20, no. 5, pp. 1260-1268. https://doi.org/10.1200/JCO.20.5.1260
Scheuer, Lauren ; Kauff, Noah ; Robson, Mark ; Kelly, Bridget ; Barakat, Richard ; Satagopan, Jaya ; Ellis, Nathan ; Hensley, Martee ; Boyd, Jeff ; Borgen, Patrick ; Norton, Larry ; Offit, Kenneth. / Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. In: Journal of Clinical Oncology. 2002 ; Vol. 20, No. 5. pp. 1260-1268.
@article{49fc0e29794d4047940f161ebb23f3c9,
title = "Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers",
abstract = "Purpose: To prospectively determine the impact of genetic counseling and testing on risk-reduction strategies and cancer incidence in a cohort of individuals at hereditary risk for breast and ovarian cancer. Patients and Methods: Two hundred fifty-one individuals with BRCA mutations were identified at a single comprehensive cancer center from May 1, 1995, through October 31, 2000. Uniform recommendations regarding screening and preventive surgery were provided in the context of genetic counseling. Patients were followed for a mean of 24.8 months (range, 1.6 to 66.0 months) using standardized questionnaires, chart reviews, and contact with primary physicians. Results: Frequency of cancer surveillance by physical examinations and imaging studies increased after genetic counseling and testing. Twenty-one breast, ovarian, primary peritoneal, or fallopian tube cancers were detected after receipt of genetic test results. Among 29 individuals choosing risk-reducing mastectomy after testing, two were found to have occult intraductal breast cancers. Among 90 individuals who underwent risk-reducing salpingo-oophorectomy, one early-stage ovarian neoplasm and one early-stage fallopian tube neoplasm were found. Radiographic or tumor marker-based screening detected six breast cancers, five of which were stage 0/1, one early-stage primary peritoneal cancer, and three stage I or II ovarian cancers. Six additional breast cancers were detected by physical examination between radiographic screening intervals; four of these six tumors were stage I. No stage III or stage IV malignancies were detected after genetic testing. Conclusion: This study provides prospective evidence that genetic counseling and testing increased surveillance and led to risk-reducing operations, which resulted in diagnosis of early-stage tumors in patients with BRCA1 and BRCA2 mutations.",
author = "Lauren Scheuer and Noah Kauff and Mark Robson and Bridget Kelly and Richard Barakat and Jaya Satagopan and Nathan Ellis and Martee Hensley and Jeff Boyd and Patrick Borgen and Larry Norton and Kenneth Offit",
year = "2002",
month = "3",
day = "1",
doi = "10.1200/JCO.20.5.1260",
language = "English (US)",
volume = "20",
pages = "1260--1268",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "5",

}

TY - JOUR

T1 - Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers

AU - Scheuer, Lauren

AU - Kauff, Noah

AU - Robson, Mark

AU - Kelly, Bridget

AU - Barakat, Richard

AU - Satagopan, Jaya

AU - Ellis, Nathan

AU - Hensley, Martee

AU - Boyd, Jeff

AU - Borgen, Patrick

AU - Norton, Larry

AU - Offit, Kenneth

PY - 2002/3/1

Y1 - 2002/3/1

N2 - Purpose: To prospectively determine the impact of genetic counseling and testing on risk-reduction strategies and cancer incidence in a cohort of individuals at hereditary risk for breast and ovarian cancer. Patients and Methods: Two hundred fifty-one individuals with BRCA mutations were identified at a single comprehensive cancer center from May 1, 1995, through October 31, 2000. Uniform recommendations regarding screening and preventive surgery were provided in the context of genetic counseling. Patients were followed for a mean of 24.8 months (range, 1.6 to 66.0 months) using standardized questionnaires, chart reviews, and contact with primary physicians. Results: Frequency of cancer surveillance by physical examinations and imaging studies increased after genetic counseling and testing. Twenty-one breast, ovarian, primary peritoneal, or fallopian tube cancers were detected after receipt of genetic test results. Among 29 individuals choosing risk-reducing mastectomy after testing, two were found to have occult intraductal breast cancers. Among 90 individuals who underwent risk-reducing salpingo-oophorectomy, one early-stage ovarian neoplasm and one early-stage fallopian tube neoplasm were found. Radiographic or tumor marker-based screening detected six breast cancers, five of which were stage 0/1, one early-stage primary peritoneal cancer, and three stage I or II ovarian cancers. Six additional breast cancers were detected by physical examination between radiographic screening intervals; four of these six tumors were stage I. No stage III or stage IV malignancies were detected after genetic testing. Conclusion: This study provides prospective evidence that genetic counseling and testing increased surveillance and led to risk-reducing operations, which resulted in diagnosis of early-stage tumors in patients with BRCA1 and BRCA2 mutations.

AB - Purpose: To prospectively determine the impact of genetic counseling and testing on risk-reduction strategies and cancer incidence in a cohort of individuals at hereditary risk for breast and ovarian cancer. Patients and Methods: Two hundred fifty-one individuals with BRCA mutations were identified at a single comprehensive cancer center from May 1, 1995, through October 31, 2000. Uniform recommendations regarding screening and preventive surgery were provided in the context of genetic counseling. Patients were followed for a mean of 24.8 months (range, 1.6 to 66.0 months) using standardized questionnaires, chart reviews, and contact with primary physicians. Results: Frequency of cancer surveillance by physical examinations and imaging studies increased after genetic counseling and testing. Twenty-one breast, ovarian, primary peritoneal, or fallopian tube cancers were detected after receipt of genetic test results. Among 29 individuals choosing risk-reducing mastectomy after testing, two were found to have occult intraductal breast cancers. Among 90 individuals who underwent risk-reducing salpingo-oophorectomy, one early-stage ovarian neoplasm and one early-stage fallopian tube neoplasm were found. Radiographic or tumor marker-based screening detected six breast cancers, five of which were stage 0/1, one early-stage primary peritoneal cancer, and three stage I or II ovarian cancers. Six additional breast cancers were detected by physical examination between radiographic screening intervals; four of these six tumors were stage I. No stage III or stage IV malignancies were detected after genetic testing. Conclusion: This study provides prospective evidence that genetic counseling and testing increased surveillance and led to risk-reducing operations, which resulted in diagnosis of early-stage tumors in patients with BRCA1 and BRCA2 mutations.

UR - http://www.scopus.com/inward/record.url?scp=0036498727&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036498727&partnerID=8YFLogxK

U2 - 10.1200/JCO.20.5.1260

DO - 10.1200/JCO.20.5.1260

M3 - Article

VL - 20

SP - 1260

EP - 1268

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 5

ER -